Brief: Regenxbio Q3 License & Royalty Revenue USD 23.605 Million
06/11/2025 12:05
Nov 06 (Reuters) - Regenxbio Q3 operating expenses USD 82.144 million. Q3 net income USD -61.941 million
- $541.79m
- $568.63m
- $170.44m
Nov 06 (Reuters) - Regenxbio Q3 operating expenses USD 82.144 million. Q3 net income USD -61.941 million